Biosimilar Manufacturing solution center
-
Dual Membrane Preconditioning Can Improve Concentration, Cut HCPs
10/27/2025
Research from Penn State, the FDA, and Takeda shows how combination filtration and purification steps improve output and reduce impurities.
-
Cell Culture Media Filtration: Evaluating Cell Culture Performance
10/23/2025
Cell culture performance remained consistent across PES and PVDF filters, even under worst-case filtration conditions. Discover a practical framework for evaluating membrane impact on CHO cell growth.
-
New Guide Aims To Build Robust Framework For Digital Validation Tools
10/22/2025
The ISPE's new guide addresses software for managing digital assets related to qualification, verification, validation, and compliance assurance.
-
Pfizer's Accord For A Healthier World Program Challenges Stability Study Norms
10/22/2025
The company developed a novel approach to address the historic lack of stability testing for underserved parts of the world, near the equator.
-
The 9 Fastest-Growing Outsourcing Segments
10/21/2025
Capacity isn’t the choke point—capability is; this piece ranks nine fast-growing outsourcing segments and shows sponsors how to win by locking in modality-proven partners early.
-
Takeda Reimagines Biopharma Quality For The Digital Age
10/21/2025
Artificial intelligence, even in its current form, is especially good at synthesizing large data sets. Here's how one company makes the most of it.
-
How Lipid Nanoparticles Enable Next-Gen Delivery
10/20/2025
Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
Streamline Process Development, Digitize Data, And Maximize Your Investments
10/20/2025
Discover how AI, digital twins, and automation are transforming biomanufacturing by cutting costs, improving quality, and accelerating timelines for smarter, more efficient production.
-
100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing
10/17/2025
Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.
-
Risk-Based Analytical Method Selection In Cleaning Validation Using ASTM International Standards
10/14/2025
This in-depth article describes risk in cleaning and provides a science- and risk-based framework for selecting analytical methods using ASTM International standards.